 | SourceWatch needs your financial support to survive and thrive. If you've found this information on the people, organizations, and issues shaping the public agenda helpful, please make a tax-deductible donation now. |
Amgen
From SourceWatch
 |
This article is part of the Center for Media & Democracy's spotlight on global corporations. |
Amgen is a large pharmaceutical company based in Thousand Oaks, California.
It manufactures pharmaceuticals to treat cancer, kidney disease, inflammation and metabolic diseases. The company's anti-anemia drugs, Epogen and Aranesp account for over a third of its sales. Enbrel, another leading drug, treats rheumatoid arthritis and is one of it's best sellers. The company has a promising drug pipeline and marketing alliances with Japanese brewer and pharmaceutical company Kirin, Johnson & Johnson, and others drug companies. Amgen sells primarily through wholesale distributors in North America and Europe. The company has 16,900 employees. [1] In the fiscal year ending in December 2008, Amgen recorded sales of over 15 billion dollars and a net income of over 4 billion dollars. [2]
Contents |
Animal testing
Amgen does animal testing.
Animals by species, numbers & location (United States)
- Amgen, Thousand Oaks, California [3]
Facility information, progress reports & USDA-APHIS reports
For links to copies of this facility's U.S. Department of Agriculture reports indicating species, number of animals used and other information visit Stop Animal Experimentation Now Facility Reports and Information, U.S. Department of Agriculture-Animal Plant Health Inspection reports. This Web site lists each of the 50 states; each state's name links to biomedical research facilities in that state, and to PDF copies of government documents where the facilities must report their animal usage.
Political contributions
Amgen gave $732,500 to federal candidates in the 2006 election through its political action committee - 34% to Democrats and 65% to Republicans. [4]
Lobbying
The company spent $10,220,000 for lobbying in 2006. About half the money was spent using in-house lobbyist and half using some 30 lobbying firms. Some of the lobbying firms were Covington & Burling, Podesta Group, Dutko Worldwide, Mehlman Vogel Castagnetti, King & Spalding, Alpine Group, HillCo Partners LLC, Tarplin, Downs & Young, and The Duberstein Group. [5]
Personnel
Key executives and 2006 pay: [6]
- Kevin W. Sharer, Chairman and Chief Executive Officer, $1,480,000
- George J. Morrow, Executive Vice President of Global Commercial Operations, $1,130,000
- Roger M. Perlmutter, Executive Vice President of R&D, $1,080,000
Selected Amgen board members: [7]
- Jerry D. Choate, Retired Chairman and CEO, The Allstate Corporation
- Gilbert S. Omenn, Former CEO, University of Michigan Health System
- Judith C. Pelham, President Emeritus, Trinity Health
- Vance D. Coffman, Former CEO of Lockheed Martin
Contact
Amgen
1 Amgen Center Drive
Thousand Oaks, CA 91320
Phone: 805-447-1000
Fax: 805-447-1010
Web address: http://www.amgen.com
Articles & sources
Sourcewatch articles
References
- ↑ Amgen Profile, Hoovers, accessed December 2008
- ↑ Key Amgen Financials, Hoovers, accessed December 2009
- ↑ Research Facilities: Amgen, Thousand Oaks, California, Humane Society of the United States, accessed May 2009
- ↑ 2006 PAC Summary Data, Open Secrets, accessed August 2007.
- ↑ Amgen lobbying expenses, Open Secrets.
- ↑ Amgen Key Executives, Yahoo Finance, accessed August 2007.
- ↑ Board of Directors, Amgen, accessed August 2007.
